Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03517722
Recruitment Status : Terminated (Study terminated early as a result of the outcome of the pre-planned Interim Analysis)
First Posted : May 7, 2018
Last Update Posted : April 14, 2021
Sponsor:
Information provided by (Responsible Party):
Janssen Research & Development, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 5, 2020
Actual Study Completion Date : November 5, 2020